Biodistribution of Amikacin Solid Lipid Nanoparticles after Pulmonary Delivery
Figure 5
Amikacin concentration in spleen, liver, stomach, and intestine after (a) i.v. and (b) pulmonary administration of SLNs (, drug concentrations in liver, intestine, and spleen are significantly different from stomach at 2 and 6 h after administration ).